Preferred Label : Insulin Glargine;

NCIt related terms : insulin glargine recombinant; Lantus;

NCIt definition : A recombinant human insulin analog with long-acting, blood glucose-lowering activity. Insulin glargine, like regular types of human insulin, regulates glucose metabolism by binding to insulin receptors on muscle and fat cells, thereby facilitating the cellular uptake of glucose. This lowers blood glucose levels. At the same time, insulin glargine inhibits the liver's conversion of stored glycogen into glucose, which also contributes to lower blood glucose levels. Insulin glargine also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. (NCI05);

Alternative definition : NCI-GLOSS: A drug used to control the amount of sugar in the blood of patients with diabetes. It is a form of the hormone insulin that is made in the laboratory. Insulin glargine controls blood sugar longer than insulin does. It is a type of therapeutic insulin.;

UNII : 2ZM8CX04RZ;

CAS number : 160337-95-1;

Drug name : Lantus;

Chemical formula : C267H404N72O78S6;

Codes from synonyms : CDR0000658820; CDR0000658817; CDR0000658818;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://pgtmsite.files.wordpress.com/2024/01/insulineglargine_pgtm_20050922.pdf
2005
Canada
drug information
insulin
Insulin Glargine
Insulin Glargine

---
Nous contacter.
25/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.